Holen Sie sich die Stockscreener-App
0.00
100.00%
-21.64
Handel nachbörslich:
21.65
21.65
+
Schlusskurs vom Vortag:
$21.64
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$2.12B
Einnahmen:
$248.52M
Nettoeinkommen (Verlust:
$-278.00K
KGV:
0.00
EPS:
-0.0055
Netto-Cashflow:
$36.82M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$23.57
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Firmenname
Avadel Pharmaceuticals Plc
Sektor
Telefon
636-449-1830
Adresse
10 EARLSFORT TERRACE, DUBLIN 2
Compare AVDL vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
0.00 | 2.12B | 248.52M | -278.00K | 36.82M | -0.0055 |
TAK
Takeda Pharmaceutical Co Adr
|
15.47 | 49.39B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.77 | 39.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.20 | 36.66B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
75.89 | 33.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
538.30 | 22.78B | 3.17B | 1.29B | 1.01B | 27.09 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-23 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-09-03 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-07-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-06-12 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-03-05 | Bestätigt | H.C. Wainwright | Buy |
| 2024-03-05 | Bestätigt | Needham | Buy |
| 2024-03-05 | Bestätigt | Oppenheimer | Outperform |
| 2024-02-06 | Eingeleitet | UBS | Buy |
| 2022-11-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-08-10 | Herabstufung | Jefferies | Buy → Hold |
| 2022-07-28 | Fortgesetzt | Craig Hallum | Buy |
| 2022-05-26 | Herabstufung | Stifel | Buy → Hold |
| 2021-09-23 | Eingeleitet | Needham | Buy |
| 2020-07-31 | Eingeleitet | Oppenheimer | Outperform |
| 2020-07-21 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-03 | Eingeleitet | Jefferies | Buy |
| 2020-03-12 | Eingeleitet | Stifel | Buy |
| 2020-02-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-30 | Eingeleitet | Craig Hallum | Buy |
| 2019-06-14 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2019-02-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
Alle ansehen
Avadel Pharmaceuticals Plc Aktie (AVDL) Neueste Nachrichten
Avadel Pharmaceuticals PLC (AVDL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Alkermes: "Buy" On Avadel Acquisition And Positive NT2 Data With Alixorexton (NASDAQ:ALKS) - Seeking Alpha
Avadel Pharmaceuticals PLC (AVDL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Avadel Pharmaceuticals PLC - TradingKey
Avadel Pharmaceuticals PLC (AVDL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Avadel Pharmaceuticals PLC (AVDL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Avadel Pharmaceuticals PLC (AVDL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Avadel Pharmaceuticals PLC (AVDL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Avadel Pharmaceuticals PLC (AVDL) Institutional Confidence - TradingKey
Alkermes to present new data on Alixorexton, LUMRYZ - TipRanks
Avadel shares jump after receiving higher $23-per-share takeover proposal - MSN
Alkermes plc stock (IE00B56GVS15): M&A deal with Avadel and fresh analyst signals put focus on futur - AD HOC NEWS
Alkermes Sees Upside To Its Avadel Buy With Phase III Lumryz Win In IH - Citeline News & Insights
Race For Avadel Heats Up: Alkermes Raises Offer To Secure $2.37B Deal After Lundbeck Challenge - MSN
Alkermes plc Q1 2026 10-Q: Financial Highlights, Risk Factors, and Forward-Looking Statements - Minichart
Alkermes Q1 2026 slides: Avadel deal drives revenue beat - Investing.com
Alkermes earnings on deck: Can Lumryz offset Avadel deal costs? By Investing.com - Investing.com Nigeria
Alkermes earnings on deck: Can Lumryz offset Avadel deal costs? - Investing.com
Avadel Pharmaceuticals 2025 Financial Results, Alkermes Acquisition, and LUMRYZ Commercial Highlights - Minichart
Alkermes (NASDAQ: ALKS) details Avadel buyout terms and 2025 results - Stock Titan
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Avadel Stock Rises After Acquisition Offer By Alkermes - MSN
Leerink Partners Downgrades Avadel Pharmaceuticals (AVDL) - MSN
Avadel (AVDL) Gets 26% Boost on Takeover Bid - MSN
Death Cross: What are the future prospects of Avadel Pharmaceuticals plcMarket Volume Summary & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Fed Watch: Is now the right time to enter Avadel Pharmaceuticals plc2026 Market Sentiment & Risk Managed Investment Signals - baoquankhu1.vn
Travel Stocks: Can Avadel Pharmaceuticals plc navigate macro headwinds2026 EndofYear Setup & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Analyst Downgrade: Is Avadel Pharmaceuticals plc vulnerable to short sellers2026 Rallies & Daily Momentum Trading Reports - baoquankhu1.vn
Signal Recap: Should I hold or sell Avadel Pharmaceuticals plc nowMarket Volume Report & AI Driven Stock Movement Reports - baoquankhu1.vn
Jefferies Downgrades Avadel Pharmaceuticals (AVDL) - MSN
Wells Fargo Initiates Coverage of Avadel Pharmaceuticals (AVDL) with Equal-Weight Recommendation - MSN
Risk Check: What is the dividend yield of Avadel Pharmaceuticals plc2026 Big Picture & Growth Oriented Trading Recommendations - baoquankhu1.vn
Aug Patterns: What is the earnings history of Avadel Pharmaceuticals plc2026 Momentum Check & Capital Protection Trade Alerts - baoquankhu1.vn
Update Recap: What are the future prospects of Avadel Pharmaceuticals plc - baoquankhu1.vn
EBITDA per share of Avadel Pharmaceuticals plc – LS:A2DJ5B - TradingView
Free cash flow per share of Avadel Pharmaceuticals plc – LS:A2DJ5B - TradingView
Avadel (AVDL) Soars to 10-Year High on Brewing Bidding War - MSN
Avadel Pharmaceuticals plc Financial Disclosures & Filings - TradingView
Avadel Pharmaceuticals (AVDL) Stock Analysis: Evaluating the Prospects of a Biopharmaceutical Innovator - DirectorsTalk Interviews
Avadel Pharmaceuticals Shares Climb on $2.1 Billion Acquisition by Alkermes - MSN
AVDL Avadel Pharmaceuticals (NASDAQ) $21.64 05 Mar 2026: earnings set to guide next move - Meyka
Pullback Watch: Should I hold or sell Avadel Pharmaceuticals plc now2025 Market Trends & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Avadel Merger Finalized as Market Focus Shifts to Clinical Pipeline - AD HOC NEWS
Alkermes Pivots Deeper Into Sleep Medicine After Avadel Deal, Details Orexin Phase 3 at TD Cowen - Yahoo Finance
Avadel Pharmaceuticals plc (AVDL) Stock Analysis: Navigating the Healthcare Sector with a Promising 54.9% Revenue Growth - DirectorsTalk Interviews
Alkermes plc Announces CEO Succession Plan - Business Wire
Quarterly Risk: Is Avadel Pharmaceuticals plc a good stock for dollar cost averaging2025 AllTime Highs & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Avadel Pharmaceuticals (AVDL) to Release Earnings on Monday - Defense World
[15-12G] AVADEL PHARMACEUTICALS PLC SEC Filing - Stock Titan
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Cross Above 200-Day Moving Average – What’s Next? - Defense World
Is Avadel Pharmaceuticals plc vulnerable to short sellers2025 Top Gainers & Short-Term Trading Opportunity Alerts - mfd.ru
Finanzdaten der Avadel Pharmaceuticals Plc-Aktie (AVDL)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.44%
4.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):